Global Plasma Fractionation Market Size Study, by Product (Immunoglobulin, Coagulation Factor Concentrates, Albumin, Proteases Inhibitors, Others) by Application (Neurology, Immunology, Homology, Critical Care, Pulmonology, Rheumatology, Others) by End Use (Hospitals & Clinic, Clinical Research Laboratories, Academic Institutes) by Regional Forecasts 2017-2025
-
Product Code:
RP-ID-10013263 -
Published Date:
21 Oct 2022 -
Region:
Global
-
Pages:
180 -
Category:
Healthcare & Pharmaceuticals -
Publisher:
Pub-ID-14
Impact Analysis on the Growth of Market
Inflation and Looming Recession to Haunt Businesses:
In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.
....
The Research Report is Updated with 2022 Base Year, 2023 Estimated year and Forecast till 2035 with Market Insights.
With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2022 as base year, 2023 as estimated year and forecast to 2035. This will have market drivers, recovery rate in the market, insights and competitive analysis.
Market Overview:
Translate Report
Global Plasma Fractionation Market valued approximately USD 19 million in 2016 is anticipated to grow with a healthy growth rate of more than 6.50% over the forecast period 2017-2025. Key factors which are providing growth to the market are the increasing use of immunoglobulins in several therapeutic areas, increasing respiratory diseases, growing geriatric population across the world, and AATD driving the approval of alpha-1-antitrypsin, and growing plasma collection. However, limited reimbursement policies and high cost, are the major restraining factor which hinder the growth of this market.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Products:
 Immunoglobulin
 Coagulation Factor Concentrates
 Albumin
 Protease Inhibitors
 Others
By Application:
 Neurology
 Immunology
 Homology
 Critical Care
 Pulmonology
 Hemoto-Oncology
 Rheumatology
 Others
By End Use:
 Hospitals & Clinics
 Clinical Research Laboratories
 Academic Institutes
By Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
 Asia Pacific
o China
o India
o Japan
 Latin America
o Brazil
o Mexico
 Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2015
Base year - 2016
Forecast period - 2017 to 2025
Some of the key manufacturers involved in the market CSL, Grifols, Shire, Octapharma, Kedrion, LFB, Biotest, Sanquin, China Biologic Products, Bio Prodcuts Laboratory (BPO), Japan Blood Products Organization, Green Cross Corporation, Shanghai Raas Blood Products Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.
Target Audience of the Global Plasma Fractionation Market in Market Study:
 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors
Geography Analysis:
The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:
- North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys & Opportunity Outlook
- Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook
.
Please enter your personal details below
Shire
Octapharma
Kedrion
LFB
Biotest
Sanquin
China Biologic Products
Bio Prodcuts Laboratory (BPO)
Japan Blood Products Organization
Green Cross Corporation
Shanghai Raas Blood Products